Companies: 10,795·Total market cap: $144.5T
Nova Eye Medical Limited

Nova Eye Medical Limited

ELXMFOTCHealthcare● Active
$0.00
$-0.01(-86.72%)
Market Cap$541249
P/E Ratio—
52W High$0.1
52W Low$0.0019
Shares OutstandingFinancialsRevenue

Nova Eye Medical Limited (ELXMF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

ELXMF · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
247.3M▲ +21.16% YoY Change
FY · as of Jun 30, 2025 · Reported in AUD
vs 204.1M in FY 2024
Diluted Shares Outstanding
247.3M
incl. options, RSUs, convertibles
Dilution Spread
+-0.00%
Diluted vs Basic
YoY Change
+21.16%
year-over-year
Float (Free Float)
233.4M
publicly tradable shares
81.9% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+18.5%
2022 → 2025
5-Year CAGRincreasing
+10.9%
2020 → 2025
10-Year CAGRincreasing
+8.7%
2015 → 2025
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 247.3M
247.3M
+21.16%
FY 2024
Diluted Shares: 204.1M
204.1M
+27.46%
FY 2023
Diluted Shares: 160.2M
160.2M
+7.83%
FY 2022
Diluted Shares: 148.5M
148.5M
+0.69%
FY 2021
Diluted Shares: 147.5M
147.5M
+0.03%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs ELXMF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+911.6%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+881.9%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+619.8%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+526.7%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+267.9%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+263.1%
#7
Nova Eye Medical LimitedELXMF
Nova Eye Medical LimitedYOU
247.3M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Nova Eye Medical Limited (ELXMF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of June 30, 2025, Nova Eye Medical Limited reports 247.3M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Nova Eye Medical Limited's basic shares outstanding (247.3M) represents currently issued shares. Diluted shares outstanding (247.3M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +-0.00%.

Shares Outstanding vs. Float (Free Float)

Nova Eye Medical Limited's float is 233.4M (81.9% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float233.4M(81.9%)
Outstanding284.9M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · AUD

About shares outstanding & methodology

Nova Eye Medical Limited (ELXMF) shares outstanding history from 2006 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Nova Eye Medical Limited shares outstanding for the fiscal year ending June 30, 2025 were 247.3M, a 21.16% increase year-over-year. Nova Eye Medical Limited FY 2025 shares outstanding were 247.3M, a +21.16% increase from FY 2024.

Nova Eye Medical Limited is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +8.7% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

ELXMF shares outstanding · 4 questions

As of June 30, 2025, Nova Eye Medical Limited (ELXMF) has approximately 247.3M basic shares outstanding and 247.3M diluted shares outstanding. This represents a +21.16% year-over-year increase from FY 2024 (204.1M). The increase may reflect equity compensation issuances or secondary offerings.

ELXMF shares outstandinghow many shares does ELXMF haveELXMF basic shares 2025ELXMF diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Nova Eye Medical Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09